First 100 participants enrolled across Europe and US in largest trial ever performed on glioblastoma patients using ultrasound-based blood-brain barrier openingParis, France, April 22, 2025 — Carthera ...

The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorderPlan to initiate ...

As dark clouds closed in on the gathering of people huddled beneath a tent near the construction site of the new Orphans of ...

Del-desiran is the first investigational treatment for DM1 to receive Orphan Drug designation in Japan. Del-desiran has also received Breakthrough Therapy, Orphan Drug and Fast Track designations ...

Rochester, N.Y. — A small gray-looking block plays a crucial part in Krittika Goyal’s research at the Rochester Institute of Technology. “This is a biomimetic skin phantom. It consists of two layers.

grows the Ohio Department of Natural Resource’s budget line for such “orphan well” plugging to more than $73 million. That’s funded via oil and gas permit fees and severance taxes.

April 07, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients ...

Call it the revenge of the widows and orphans. As trade tariffs and geopolitical turmoil trigger steep losses for stocks around the world, one of the market’s traditionally most conservative ...

HLX22 received orphan drug designation, offering incentives like tax credits and market exclusivity to accelerate development for gastric cancer treatment. Phase 2 trial results showed HLX22 improved ...